MHRA approves Nucala for eosinophilic COPD in adults on triple therapy - PharmaTimes New biologic option shown to reduce exacerbations and extend time to first flare

#MHRA #GSK #Nucala #mepolizumab #eosinophilicCOPD #tripletherapy #biologics #UK #addonmaintenancetreatment #uncontrolledCOPD #MATINEE #METREX #KingsCentreforLungHealth #RespiratoryMedicine #COPDpatients #NICE #emergencyhospitaladmissions #COPDExacerbations #SMC #reimbursement
zurl.co/ro5Og

Another application of #MonoclonalAntibodies hopefully some of my patients will benefit… #COPDExacerbations www.thelancet.com/action/showP...